Genascence Appoints Jeymi Tambiah as Chief Medical Officer

UF Startup Genascence Corporation, a clinical-stage biotechnology company revolutionizing the treatment of prevalent musculoskeletal diseases with gene therapy, announced the appointment of Jeymi Tambiah as its chief medical officer. Dr. Tambiah is an accomplished physician-scientist with more than fifteen years’ biopharmaceutical industry experience creating and leading strategies for medical affairs, clinical development, and drug development programs. He also brings deep experience in translational medicine, commercialization, and health outcomes research to Genascence.

Read more about Genascence Appoints Jeymi Tambiah as Chief Medical Officer.